| P50 | author | Helen Blau | Q15989699 |
| P2093 | author name string | Robert C Robbins | |
| | Mark L Koransky | |
| P2860 | cites work | Identification of the KDR tyrosine kinase as a receptor for vascular endothelial cell growth factor | Q24294262 |
| | The fms-like tyrosine kinase, a receptor for vascular endothelial growth factor | Q24328901 |
| | Protein ligands to HuR modulate its interaction with target mRNAs in vivo | Q24681529 |
| | Tumor angiogenesis: therapeutic implications | Q27860595 |
| | Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis | Q28140740 |
| | High affinity VEGF binding and developmental expression suggest Flk-1 as a major regulator of vasculogenesis and angiogenesis | Q28594191 |
| | Vascular endothelial growth factor is a secreted angiogenic mitogen | Q28646475 |
| | Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene | Q29547732 |
| | Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele | Q29547733 |
| | Vascular endothelial growth factor (VEGF) and its receptors | Q29615390 |
| | Efficacy of intracoronary or intravenous VEGF165 in a pig model of chronic myocardial ischemia. | Q32055174 |
| | The vascular endothelial growth factor family: identification of a fourth molecular species and characterization of alternative splicing of RNA. | Q33301664 |
| | Gene therapy for myocardial angiogenesis | Q33699845 |
| | Angiogenesis gene therapy: phase I assessment of direct intramyocardial administration of an adenovirus vector expressing VEGF121 cDNA to individuals with clinically significant severe coronary artery disease | Q33869745 |
| | Direct myocardial revascularization and angiogenesis--how many patients might be eligible? | Q33873652 |
| | Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells | Q34047111 |
| | Treatment of thromboangiitis obliterans (Buerger's disease) by intramuscular gene transfer of vascular endothelial growth factor: preliminary clinical results | Q34068061 |
| | Therapeutic angiogenesis. A single intraarterial bolus of vascular endothelial growth factor augments revascularization in a rabbit ischemic hind limb model | Q34125421 |
| | Upregulation of vascular endothelial growth factor expression induced by myocardial ischaemia: implications for coronary angiogenesis | Q34292693 |
| | Blood vessel maturation: vascular development comes of age | Q34489077 |
| | Tumor vascular permeability factor stimulates endothelial cell growth and angiogenesis | Q34578752 |
| | Clinical evidence of angiogenesis after arterial gene transfer of phVEGF165 in patient with ischaemic limb | Q39425647 |
| | Regulation of hypoxia-induced angiogenesis: a chaperone escorts VEGF to the dance | Q39946802 |
| | Selective ablation of immature blood vessels in established human tumors follows vascular endothelial growth factor withdrawal | Q40848490 |
| | VEGF gene delivery to myocardium: deleterious effects of unregulated expression | Q41757138 |
| | Isolation of a tumor factor responsible for angiogenesis | Q42835506 |
| | Gene therapy with vascular endothelial growth factor for inoperable coronary artery disease | Q45862672 |
| | Direct intramuscular gene transfer of naked DNA encoding vascular endothelial growth factor augments collateral development and tissue perfusion | Q45880288 |
| | Constitutive expression of phVEGF165 after intramuscular gene transfer promotes collateral vessel development in patients with critical limb ischemia | Q45886388 |
| | Gene therapy for myocardial angiogenesis: initial clinical results with direct myocardial injection of phVEGF165 as sole therapy for myocardial ischemia | Q45890406 |
| | Transcriptional control: rheostat converted to on/off switch | Q46965292 |
| | Biologic bypass with the use of adenovirus-mediated gene transfer of the complementary deoxyribonucleic acid for vascular endothelial growth factor 121 improves myocardial perfusion and function in the ischemic porcine heart | Q64382204 |
| | Vascular permeability factor, an endothelial cell mitogen related to PDGF | Q69116052 |
| | VEGF improves myocardial blood flow but produces EDRF-mediated hypotension in porcine hearts | Q71139703 |
| | Magnetic resonance mapping demonstrates benefits of VEGF-induced myocardial angiogenesis | Q71563623 |
| | Angiogenic-induced enhancement of collateral blood flow to ischemic myocardium by vascular endothelial growth factor in dogs | Q71623264 |
| | Heparin Affinity: Purification of a Tumor-Derived Capillary Endothelial Cell Growth Factor | Q72726491 |
| | Effect of intracoronary recombinant human vascular endothelial growth factor on myocardial perfusion: evidence for a dose-dependent effect | Q73358586 |
| | The well-tempered vessel | Q73820249 |
| | Left ventricular electromechanical mapping to assess efficacy of phVEGF(165) gene transfer for therapeutic angiogenesis in chronic myocardial ischemia | Q74232803 |
| | Hypoxic stabilization of vascular endothelial growth factor mRNA by the RNA-binding protein HuR | Q74299380 |
| P433 | issue | 3 | |
| P921 | main subject | cardiovascular disease | Q389735 |
| P304 | page(s) | 108-114 | |
| P577 | publication date | 2002-04-01 | |
| P1433 | published in | Trends in Cardiovascular Medicine | Q1850265 |
| P1476 | title | VEGF gene delivery for treatment of ischemic cardiovascular disease | |
| P478 | volume | 12 | |